These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FGFR4, CD334, 2264, ENSG00000160867, P22455, MGC20292, TKF, JTK2 AND Diagnosis
3 results:

  • 1. cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer.
    Giordano G; Febbraro A; Tomaselli E; Sarnicola ML; Parcesepe P; Parente D; Forte N; Fabozzi A; Remo A; Bonetti A; Manfrin E; Ghasemi S; Ceccarelli M; Cerulo L; Bazzoni F; Pancione M
    J Exp Clin Cancer Res; 2015 Oct; 34():108. PubMed ID: 26427914
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor-associated antigens obtained from protein and phage microarrays.
    Barderas R; Babel I; Díaz-Uriarte R; Moreno V; Suárez A; Bonilla F; Villar-Vázquez R; Capellá G; Casal JI
    J Proteomics; 2012 Aug; 75(15):4647-55. PubMed ID: 22465712
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.
    Babel I; Barderas R; Díaz-Uriarte R; Martínez-Torrecuadrada JL; Sánchez-Carbayo M; Casal JI
    Mol Cell Proteomics; 2009 Oct; 8(10):2382-95. PubMed ID: 19638618
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.